BeStock  
Stocks › Biotechnology › BMRN

Biomarin Pharmaceutical BMRN

US equityMarket cap rank #1288Biotechnology
$60.41 −$1.01 (-1.64%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $60.02 -0.65%
Open$61.53
Prev close$61.42
Day range$59.84 – $62.01
Volume6.06M
Market cap$11.70B
P/E (TTM)–
Dividend yield–

BMRN Stock News

Headlines matching Biomarin Pharmaceutical or the BMRN ticker, most recent first.

  • J.P. Morgan Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Announces Target Price $86Market news · 21 Sep 2026 · Direct mention
  • Piper Sandler Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Raises Target Price to $90 PositiveMarket news · 2 Sep 2026 · Direct mention
  • Cantor Fitzgerald Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Raises Target Price to $86 PositiveMarket news · 2 Sep 2026 · Direct mention
  • Guggenheim Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Cuts Target Price to $86 NegativeMarket news · 18 Sep 2026 · Direct mention
  • BMO Capital Upgrades Biomarin Pharmaceutical(BMRN.US) to Buy Rating, Raises Target Price to $97 PositiveMarket news · 16 Sep 2026 · Direct mention
  • Morgan Stanley Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Maintains Target Price $124Market news · 16 Sep 2026 · Direct mention
  • Biomarin Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Plenge Robert MSEC · 15 Sep 2026 · Related
  • Citi Maintains Biomarin Pharmaceutical(BMRN.US) With Buy RatingMarket news · 15 Sep 2026 · Direct mention
  • Biomarin Pharmaceutical | 8-K: Current reportSEC · 15 Sep 2026 · Related
  • Wells Fargo Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Maintains Target Price $80Market news · 11 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Biomarin Pharmaceutical(BMRN.US), With a Forecast Between $70 to $124Market news · 1 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Biomarin Pharmaceutical(BMRN.US), With a Forecast Between $62 to $124Market news · 8 Aug 2026 · Direct mention
  • Stifel Maintains Biomarin Pharmaceutical(BMRN.US) With Hold Rating, Maintains Target Price $70Market news · 31 Aug 2026 · Direct mention
  • Piper Sandler Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Maintains Target Price $88Market news · 26 Aug 2026 · Direct mention
  • TD Cowen Maintains Biomarin Pharmaceutical(BMRN.US) With Buy Rating, Maintains Target Price $120Market news · 21 Aug 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on BMRN.

Sign in to join the discussion.

Scroll to Top